BioSpace

Cofactor Genomics Advances Predictive Cancer Diagnostics With Landmark OncoPrism-NSCLC Study

PREDAPT Trial Validates RNA-Based Predictive Biomarker Across 1400+ Patients to Inform Immunotherapy Treatment in NSCLC ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, a leader in cancer immunotherapy ...
IEEE

Introduction to Voltage-Ramping Wafer Level Electromigration Method and Current Exponent Correction Factor for Co-Capping Metal Lines

Abstract: This paper presents a novel voltage-ramping (V-ramp) wafer-level electromigration (EM) testing method aimed at reducing testing time. The EM behavior of copper (Cu) metal lines with both ...
The Business Journals

St. Louis biotech Cofactor Genomics lands investments from Labcorp, Ascension Ventures

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis biotech company has ...
Morningstar

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks Cofactor Genomics, a ...